Bioxcel Therapeutics, Inc. · NASDAQ:BTAI
Bioxcel Therapeutics, Inc. shareholders
As of Jun 30, 2026, 44 institutions reported holding Bioxcel Therapeutics, Inc. Largest: Millennium, Oaktree Capital Management LP and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Bioxcel Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Millennium | 2.11M | +178K | Aug 14, 2026 | |
| Oaktree Capital Management LP | 1.38M | +1.14M | Aug 14, 2026 | |
| Vanguard | 1.06M | +764K | Aug 13, 2026 | |
| Oaktree Fund Advisors, LLC | 246K | +203K | Aug 14, 2026 | |
| Geode Capital | 242K | +12,083 | Aug 12, 2026 | |
| BlackRock | 179K | +95,151 | Aug 7, 2026 | |
| UBS | 158K | +105K | Aug 13, 2026 | |
| Citadel | 149K | new | Aug 14, 2026 | |
| State Street | 92,118 | no change | Aug 7, 2026 | |
| Fidelity | 90,300 | no change | Aug 13, 2026 |